RISPERDAL® CONSTA® (risperidone) Long Acting Injection

About Schizophrenia
Diagnosis of Schizophrenia
Living with Schizophrenia
About RISPERDAL CONSTA
Staying on Treatment
News Center
Resources
Patient Assistance Program
Mental Wellness.com
Links to Other Sites
Recommended Reading
Frequently Asked Questions
También en Español
Full US Prescribing Information
Sitemap
Global Resources
Tell a friend
Privacy Policy
Legal Notice
Printer Friendly
 Text Size:  S | M |  L
 
 
 
    

Links to Other Sites

 

Patient Support and Advocacy
Organizations

The National Alliance on Mental Illness (NAMI)

The National Alliance on Mental Illness, NAMI is a nonprofit, grassroots, self-help, support and advocacy organization of consumers, families, and friends of people with severe mental illnesses, such as schizophrenia, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, panic and anxiety disorders.

With more than one thousand local affiliates and fifty state organizations NAMI provides education and support, resources to combat stigma, support for increased funding for research, and advocacy for adequate health insurance, housing, rehabilitation, and jobs for people with mental illnesses and their families.

To find patient and caregiver support services in your area contact your local NAMI affiliate.

The Depression and Bipolar Support Alliance (DBSA)

The Depression and Bipolar Support Alliance (DBSA) is the country's leading patient-directed organization focusing on depression and bipolar disorder. The organization's mission is to improve the lives of people living with mood disorders. DBSA has a grassroots network of over 1,000 patient-run support groups across the country. Visit their site to find a support group in your community.

National Institute of Mental Health (NIMH)

The NIMH is a Federal agency whose mission is to reduce the burden of mental illness through research. The agency utilizes powerful scientific tools to achieve better understanding, treatment, and eventually, prevention of mental illnesses that affect millions of Americans. This Web site provides comprehensive information on mental illnesses and the available treatment options.

The National Mental Health Association (NMHA)

The National Mental Health Association (NMHA) is the country's oldest and largest nonprofit organization addressing all aspects of mental health and mental illness. With more than 340 affiliates nationwide, NMHA works to improve the mental health of all Americans, especially the 54 million individuals with mental disorders, through advocacy, education, research and service.

To find patient and caregiver support in your area contact your local NMHA support affiliate or call the NMHA Affiliate Helpline: 1-800-969-NMHA (6642)

National Alliance for Research on Schizophrenia and Depression (NARSAD)

NARSAD is a private, not-for-profit public charity 501(C)(3) organized for the purpose of raising funds for scientific research into the causes, cures, treatments and prevention of severe psychiatric brain disorders, such as schizophrenia and depression.

Schizophrenia.com

Schizophrenia.com is a not- for- profit resource center that provides information, support and education to patients, caregivers and family members whose lives have been impacted by schizophrenia. The site is run by volunteers whose lives have been impacted by the disease (patients and caregivers).

<Back to Top>


Patient support groups

Peer-to-Peer: NAMI's consumer education and recovery program

Peer-to-Peer is a unique, experiential learning program for people with any serious mental illness who are interested in establishing and maintaining their wellness and recovery. Peer-to-Peer consists of nine two-hour units and is taught by a team of three trained "mentors" who are personally experienced at living well with mental illness.

Participants come away from the course with valuable resource tools including a "relapse prevention plan" to help identify telltale feelings, thoughts, behavior or events that may warn of impending relapse and to organize for intervention, among other materials.

Peer-to-Peer currently exists in several states around the country and more states will begin to offer this program. To learn more about this program contact your state NAMI.

NAMI HelpLine: 1-800-950-NAMI [6264].

The National Alliance for the Mentally Ill (NAMI), In our own Voice Education program

The In Our Own Voice Education Program is an informational outreach program on recovery presented by trained consumers to other consumers, families, students, and professionals, and to all other people who want to learn about mental illness. It is designed to offer insight into how people with serious mental illness cope with the realities of their disorders while recovering and reclaiming productive lives that have meaning and dignity. It provides an opportunity for consumers to gain self-confidence, self-esteem, and income while serving as role models for the community — and as living proof that mental illness is nothing to be ashamed of and that recovery is an ongoing reality. NAMI HelpLine: 1-800-950-NAMI [6264].

Schizophrenics Anonymous

Schizophrenics Anonymous (S.A.) is a self-help consumer-run support group for people with schizophrenia. Like Alcoholics Anonymous, it has a program of recovery which intends to help members rise above their illness. The purpose of S.A. is to help restore dignity and sense of purpose for persons who are working for recovery from schizophrenia and other related disorders. S. A. offers fellowship, positive support, and companionship in order to achieve good mental health. The aim is to improve attitudes about the illness and its impact on people's lives and to provide members with the latest information regarding schizophrenia and its treatment.

Healthyplace.com

Healthyplace.com is a community of experts and everyday people dealing with psychological disorders who provide mental health information, support, and the opportunity to share experiences helpful to others. This online resource provides comprehensive information on psychological disorders, psychiatric medications, support groups, HealthyPlace.com Radio, a weekly live mental health radio show and more.

The International Affiliation of Compeer programs (IACP)

COMPEER, INC. is an international not- for- profit organization that matches caring, sensitive, and trained volunteers in one-to-one friendship relationships with children and adults (generally same sex) referred by mental health professionals. The Compeer program is an adjunct to therapy and is based on the concept that a volunteer's friendship, advocacy and support can offset the loneliness and isolation that accompany mental illnesses. Volunteers visit their Compeer friend for a minimum of four hours a month for a year and share a variety of social, recreational, and educational activities with their friends.

  • Compeer Group Placement volunteers may be matched with individuals who live in supervised settings.
  • Compeer's Project Homeless volunteers serve as a connection to the community – to residents of local shelters.
  • Compeer Calling addresses the needs of those who are housebound, both volunteers and those wanting a Compeer friend.
  • Compeer Youth Program provides role models for their young Compeer friends.

Partners in Community Access to Recovery and Empowerment (CARE)

Partners in CARE, an initiative of the National Mental Health Association (NMHA), addresses the treatment needs of individuals with schizophrenia and other serious mental illnesses. Partners in CARE reflect NMHA's commitment to the idea that all individuals deserve the chance to live fulfilling, productive, independent lives integrated into their communities.

<Back to Top>


Caregiver support groups

NAMI Family-to-Family Education Program

The NAMI Family-to-Family Education Program is a free 12-week course for family caregivers of individuals with severe mental illnesses. The course is taught by trained family members. The Family-to-Family curriculum focuses on schizophrenia, bipolar disorder (manic depression), clinical depression, panic disorder and obsessive-compulsive disorder (OCD). The course discusses the clinical treatment of these illnesses and teaches the knowledge and skills that family members need to cope more effectively.

Family-to-Family classes are offered in hundreds of communities across the country. All instruction and course materials are free for class participants. Contact your local NAMI affiliate to register.

Schizophrenia and Related Thought Disorders: A Repeating Workshop for Families (The Family Resource Center)

This two-week program, facilitated by Lawrence Haber, PhD, is for family members and friends of individuals in the Hartford, Connecticut, area who have schizophrenia or a related disorder. The program presents a basic understanding of schizophrenia and its treatment, along with specific suggestions to help family members and friends better cope with this illness. Call 860-545-7731.

Family Caregiver Alliance

Founded in 1977, Family Caregiver Alliance (FCA) was the first community based non-profit organization in the country to address the needs of families and friends providing long-term care at home. FCA now offers programs at national, state and local levels to support and sustain caregivers.

FCA is a public voice for caregivers, illuminating the daily challenges they face, offering them the assistance they so desperately need and deserve, and championing their cause through education, services, research and advocacy.

National Alliance for Caregiving

The National Alliance for Caregiving is dedicated to providing support to family caregivers and the professionals who help them and to increasing public awareness of issues facing family caregivers.

The National Family Caregivers Association (NFCA)

The National Family Caregivers Association (NFCA) supports, empowers, educates, and speaks up for the more than 50 million Americans who care for a chronically ill, aged, or disabled loved one. NFCA reaches across the boundaries of different diagnoses, different relationships and different life stages to address the common needs and concerns of all family caregivers.

<Back to Top>


Counseling Resources

Imagination Workshop

Imagination Workshop is a non-profit, theatre arts organization dedicated to bringing, professional artists into a working, artistic relationship with 'at risk' children in schools, psychiatric patients, and homeless individuals.

Imagination Workshop makes the arts safe and effective for all students and patients. Behind the guise of a character, even the most frightened and regressed person can reveal thoughts, desires, and needs which they cannot express as themselves. As the participants work together, they learn self-discipline, cooperation, and social skills, finding artistic passageways out of their isolation.

Imagination Workshop provides workshops at locations such as, the UCLA Neuropsychiatric Research Institute, Los Angeles; Metropolitan State Hospital, Norwalk; Lincoln Middle School, Santa Monica; Olympic High School, Santa Monica; and The Accelerated School, South Central Los Angeles.

The Substance Abuse and Mental Health Services Administration (SAMHSA)

The Substance Abuse and Mental Health Services Administration (SAMHSA), an agency of the U.S. Department of Health and Human Services (HHS), was created to focus attention, programs, and funding on improving the lives of people with or at risk for mental and substance abuse disorders. SAMHSA's vision is a life in the community for everyone. SAMHSA's mission is to build resilience and facilitate recovery for people with or at risk for substance abuse and mental illness. In collaboration with the states, national and local community-based and faith-based organizations, and public and private sector providers, SAMHSA is working to ensure that people with or at risk for a mental or addictive disorder have the opportunity for a fulfilling life that includes a job, a home, and meaningful relationships with family and friends.

Dual Recovery Anonymous™

Dual Recovery Anonymous™ is an independent, non-professional, 12-step, self-help fellowship organization for people with a dual diagnosis. The goal of the organization is to help men and women who experience the dual illnesses of chemical dependence and emotional or psychiatric illness.

<Back to Top>


Vocational Resources

The International Center for Clubhouse Development (ICCD)

The International Center for Clubhouse Development is a global network creating opportunities for people living with mental illness to be respected members of society. ICCD clubhouses are founded on the realization that recovery from serious mental illness must involve the whole person in a vital and culturally sensitive community. A clubhouse community offers respect, hope, mutuality and unlimited opportunity to access the same worlds of friendship, housing, education and employment as the rest of society. Visit the ICCD Web site at www.iccd.org to find out if there is a clubhouse in your area.

Fountain House

Fountain House is a nationally recognized center for research into the rehabilitation of individuals with mental illness. It is a key training base for the worldwide replication of Fountain House's pioneering Clubhouse Model. Increasingly, too, it is an influential voice in continuing efforts - local, statewide and national - both to promote the rights of men and women with mental illness and to battle the barriers and stigma they face. The Fountain House vision is that people with mental illness everywhere achieve their potential and are respected as coworkers, neighbors and friends." Since it's founding in New York City in 1948, Fountain House has helped over 16,000 men and women to achieve more independent, more productive and more rewarding lives.

<Back to Top>



Patient Support and Advocacy organizations
Patient support groups
Caregiver support groups
Counseling resources
Vocational resources

Patient Collage
Patient Brochure
View and download
Patient Brochure RISPERDAL CONSTA patient education brochure. Click here.

 


RISPERDAL® CONSTA® (risperidone) is used for the treatment of schizophrenia.

IMPORTANT SAFETY INFORMATION FOR RISPERDAL® CONSTA®

Elderly Patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. RISPERDAL® CONSTA® (risperidone) is not approved for the treatment of patients with dementia-related psychosis.

Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with RISPERDAL® CONSTA® and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has NMS.

Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with RISPERDAL® CONSTA® and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.

High blood sugar and diabetes have been reported with RISPERDAL® CONSTA® and similar medications. If the person being treated has diabetes or risk factors such as being overweight or a family history of diabetes, blood sugar testing should be performed at the beginning and throughout treatment with RISPERDAL® CONSTA®. Complications of diabetes can be serious and even life threatening. If signs of high blood sugar or diabetes develop, such as being thirsty all the time, going to the bathroom a lot, or feeling weak or hungry, contact your doctor.

RISPERDAL® CONSTA® and similar medications can raise the blood levels of a hormone known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin remain elevated with continued use. Some side effects seen with these medications include the absence of a menstrual period; breasts producing milk; the development of breasts by males; and the inability to achieve an erection. The connection between prolactin levels and side effects is unknown.

Some people taking RISPERDAL® CONSTA® may feel faint or lightheaded when they stand up or sit up too quickly. By standing up or sitting up slowly and following your healthcare professional's dosing instructions, this side effect can be reduced or it may go away over time.

RISPERDAL® CONSTA® may affect your alertness or driving ability; therefore, do not drive or operate machinery before talking to your healthcare professional.

RISPERDAL® CONSTA® should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.

Extrapyramidal Symptoms (EPS) are usually persistent movement disorders or muscle disturbances, such as restlessness, tremors, and muscle stiffness. If you observe any of these symptoms, talk to your healthcare professional.

Inform your healthcare professional if you become pregnant or intend to become pregnant during therapy with RISPERDAL® CONSTA®. Caution should be exercised when RISPERDAL® CONSTA® is administered to a nursing woman.

RISPERDAL® CONSTA® may make you more sensitive to heat. You may have trouble cooling off, or be more likely to become dehydrated, so take care when exercising or when doing things that make you warm.

Some medications interact with RISPERDAL® CONSTA®. Please inform your healthcare professional of any medications or supplements that you are taking. Avoid alcohol while on RISPERDAL® CONSTA®.

In a study of people taking RISPERDAL® CONSTA®, the most common side effects in the treatment of schizophrenia were headache, tremors, dizziness, restlessness, tiredness, constipation, indigestion, sleepiness, weight gain, pain in the limbs, and dry mouth.

If you have any questions about RISPERDAL® CONSTA® or your therapy, talk with your doctor.

For more information, read the Important Product Information by clicking here.

01CS1054




Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Home   Janssen.com   Site Map   Contact Us   

© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2003 – 2008. This site is published by Janssen®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. which is solely responsible for its contents. This site is intended for visitors from the United States.
This page was last updated on: Jan 18 2008 at 13:43:11 EST